TD Cowen Downgrades Agilon Health to Market Perform, Lowers Price Target to $6.5
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Gary Taylor downgraded Agilon Health (NYSE:AGL) from Outperform to Market Perform and reduced the price target from $12 to $6.5, indicating a more cautious outlook on the company's stock.
February 26, 2024 | 12:27 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Agilon Health's stock was downgraded by TD Cowen from Outperform to Market Perform, with a price target cut from $12 to $6.5.
The downgrade by a prominent analyst from a reputable firm like TD Cowen, coupled with a significant reduction in the price target, is likely to negatively impact investor sentiment and the stock price of Agilon Health in the short term. Such analyst actions often lead to immediate market reactions as investors adjust their expectations based on the new information.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100